Thursday 7 September 2017: Pre-conference Workshop

Transcription

1 Thursday 7 September 2017: Pre-conference Workshop 0900 Registrations open Welcome Immunisation coverage in New Zealand Ministry of Health Immunisation update Pharmac Update Morning Tea Pertussis update Peter McIntyre, Director of NCIRS, Australia Varicella and vaccine hesitancy Jenny Royle, Immunisation Paediatrician, UNSW Update on National Cold Chain Audit and the COOL Project Loretta Roberts & Barbara McArdle, The Immunisation Advisory Centre, The University of Auckland Lunch Breakout sessions Room 1 Having immunisation conversations with families Jenny Royle Exploring the challenges of communication Theo Brandt Room 2 RH102 Understanding immunisation coverage Ministry of Health team Schedule changes 2017 Anna Wall Room 3 RHLT03 Immunisation delivery best practice Lisbeth Alley and Trish Wells - Morris Cold chain accreditation peer moderation Bernadette Heaphy and Lynette Collis Understanding immunology Mary Nowlan A year in the life of a Schedule change! Diana Murfitt and Bernadette Heaphy LinKIDS Canterbury Learning from the NIR, to connect children with other health services Bridget Lester Vaccine safety Helen Petousis- Harris Panel discussion and questions Closing speaker Caroline McElnay 1730 Bell Technology pre-conference Workshop drinks and nibbles

2 Friday 8 September 2017: Immunisation Conference Day One Powhiri: George Taipari, Kaumatua Conference Opening Plenary Session 1: Gains and challenges for immunisation worldwide Chair: Nikki Turner Immunisation in New Zealand / Aotearoa - progress and challenges Caroline McElnay, Director of Public Health, Ministry of Health Immunisation challenges in Fiji and Pacific Litiana Volavola, National EPI coordinator, Fiji Global challenges for immunisation and vaccines (video link) Peter Hotez, President of Sabin Vaccine Institute, USA Morning Tea Concurrent Session Programmes & communication Chair: Bernadette Heaphy Not another immunisation target! Why do we need them? Rachel Webber How irrational?: A discussion of rationality and choice as to childhood vaccination. Mark Jones Vaccine impact in NZ RHLT02 Chair: Mary Nowlan Rotavirus infection in the Auckland region following the implementation of universal infant rotavirus vaccination: impact on hospitalisations and laboratory implications. Gary McAuliffe VE PCV Effectiveness of the Pneumococcal conjugate vaccines against clinically suspected Invasive Pneumococcal Disease in New Zealand. Danyon Petousis-Harris Inequities Chair: Lisbeth Alley Exploring inequities for immunisation and vaccine preventable diseases among migrant children: the Red Knot (Huahou) Study. Nadia Charania Improving immunisation coverage for Indigenous children in Queensland what more can we do? Amanda Hicks Getting the boys on board - promoting the 2017 changes to HPV immunisation. Bonnie Jones A retrospective cohort study of the impact of a Group B OMV meningococcal vaccine (MeNZB ) on hospitalisations attributable to gonorrhoea. Janine Paynter Vax Reach - a mobile, outreach vaccination program to increase vaccination coverage among vulnerable populations. Karen Bellamy Lunch

3 Friday 8 September 2017: Immunisation Conference Day One cntd. Plenary Session 2: Vaccine Safety Surveillance Chair: Helen Petousis-Harris Vaccine safety: The importance of going beyond passive surveillance - recent examples Steve Black, Professor of Pediatrics, University of Cincinnati, USA Vaccine safety monitoring How does it work now? Susan Kenyon, Principal Technical Specialist, Pharmacovigilance, Clinical Risk Management, Medsafe Vaccine safety monitoring What do we want to do in the future? Michael Tatley, Director, NZ Pharmacovigilance Centre, University of Otago Need for active surveillance in New Zealand: Panel Discussion: Steve Black, Susan Kenyon, Michael Tatley, Helen Petousis-Harris Chair: Nikki Turner Afternoon Tea Concurrent Session 2 Vaccine safety Chair: Diana Murfitt Mitigating immunisation stress RHLT02 Chair: Trish Well-Morris Disease epidemiology Chair: Tomasz Kiedryznski Cold Chain Failure. Helen August Strategies to assist in vaccinating needle phobic children. Deidre Brogan and Rosemary Joyce Epidemiology of varicella zoster infections in Australia, Meru Sheel Australia s expanding nationwide active surveillance system, AusVaxSafety, demonstrates the safety of 2017 seasonal influenza vaccines in near real time. Lucy Deng Immunisations under sedation at a tertiary paediatric hospital in Melbourne, Australia from Kirsten Perrett Breakthrough Pertussis in New Zealand infants and young children. Hannah Chisholm Post vaccination febrile seizures: Clinical severity and outcome data is reassuring. Lucy Deng Minimising Childhood Immunisation Pain using a cold-numbing device (Coolsense ). Narelle Jenkins The changing epidemiology of invasive meningococcal disease in Australia: continuing rise in meningococcal W disease. Julia Maguire Green Cross Health Conference Evening Event, Banquet Hall, Parliament: Celebrating 20 years of IMAC

4 Saturday 9 September 2015: Immunisation Conference Day Two Plenary Session 3: Vaccine preventable diseases and vaccine control strategies Chair: Caroline McElnay HPV immunisation: improving HPV protection through the school immunisation program Helen Marshall, Professor of Vaccinology, University of Adelaide Live attenuated vaccines for varicella and zoster: Evidence for effectiveness and safety Steve Black, Professor of Pediatrics, University of Cincinnati Pneumococcal vaccine effectiveness and disease control Peter McIntyre, Director of NCIRS, Australia Morning Tea Concurrent Session 3 : VPDs Opportunities to immunise Chair: Anna Wall HPV outcomes RHLT2 Chair: Rayoni Keith Working as one Cahir: Asmitha Patchay OIS Networking stream RHMZ02 Chair: Jane Grant A cost benefit analysis of the use of routine serology in reducing the Association of prior HPV vaccination This stream is specifically designed for OIS team members burden of re-immunisation in children who have undergone chemotherapy for childhood cancer. Fraser Jeffrey How useful is a "drop in" immunisation service in a tertiary paediatric hospital? Deidre Brogan and Rosemary Joyce with reduced preterm birth: a population based study. Anna Howe The impact of ten years of 4-valent HPV vaccination in Australia: what s next in HPV prevention in Australia Cyra Patel and Julia Brotherton Upper Hutt HPV initiative. Karis Harland Out with the Old, in with the Flu Diana Murfitt It s immunisation calling a statewide program to follow up children overdue for immunisation using call centre technology Amanda Hicks IMAC Outreach Immunisation Services Project Mitch Fray Prevalence of human papillomavirus Timing of Influenza and Respiratory Followed by group discussion Every opportunity in partnership. Lorraine Glover positive oropharyngeal cancer in New Zealand. Syncytial Virus Epidemic Periods in Five Distinct Regions of Argentina. Rebecca Lucas-Roxburgh Jazmin Duque Lunch

5 Saturday 9 September 2015: Immunisation Conference Day Two cntd Plenary 4: Outbreaks and vaccines on the horizon Chair: Marguerite Dalton Taming the meningococcus Helen Marshall, Professor of Vaccinology, University of Adelaide Pandemic flu Charles Blanch, Director of Emergency Management, Protection Regulation and Assurance, Ministry of Health A sneak peek into the future of vaccines Michael Nissen, Director of Scientific Affairs & Public Health for GSK Vaccines, Singapore Plenary Session 5: Looking forward Chair: Emma Best Immunisation instilling good memories Anne La Flamme, Professor, School of Biological Sciences, Victoria University of Wellington Conference conclusions and summary Emma Best, Senior Lecturer, Paediatrics, Child and Youth Health, The University of Auckland Conference Closing: Nikki Turner Poropororoaki: George Taipari, Kaumatua